Fuisz Pharma Announces Receipt of a Notice of Patent Allowance for Breath Diagnostics; The Invention addresses the Issue of Ambient Contaminants that Skew Results
June 22, 2021 08:00 ET | FUISZ LLC
Franklin, TN, June 22, 2021 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz Pharma) today announced its receipt from the United States Patent and Trademark Office (PTO) of a notice of allowance for App....
World CRISPR Gene Detection and Diagnostic Markets 2021-2025: Market has Just Gotten Started with a Handful of Small Startups - Expect the Big Players to Start Taking Notice
April 16, 2021 05:08 ET | Research and Markets
Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides -...